rsm 容诚 募集资金存放与实际使用情况鉴证报告 北京康比特体育科技股份有限公司 容诚专字|2025|100Z0608 号 容诚会计师事务所(特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查测 "进行查看"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查测 "一带" 落 募集资金存放与实际使用情况鉴证报告 18 容诚专字[2025]100Z0608 号 北京康比特体育科技股份有限公司全体股东: 我们审核了后附的北京康比特体育科技股份有限公司(以下简称康比特公司) 董事会编制的 2024 年度《募集资金存放与实际使用情况的专项报告》。 一、 对报告使用者和使用目的的限定 本鉴证报告仅供康比特公司年度报告披露之目的使用,不得用作任何其他目 的。我们同意将本鉴证报告作为康比特公司年度报告必备的文件,随其他文件一起 报送并对外披露。 二、董事会的责任 按照中国证券监督管理委员会《上市公司监管指引第 2 号 -- 上市公司募集 资金管理和使用的监管要求》、北京证券交易所《北京证券交易所股票上 ...

证券代码：833429 证券简称：康比特 公告编号：2025-029 北京康比特体育科技股份有限公司 2024 年度独立董事述职报告（张志军） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载，误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为北京康比特体育科技股份有限公司（以下简称"公司"）的独立董事， 2024 年度本人严格按照《中华人民共和国公司法》、《中华人民共和国证券法》、 《北京证券交易所股票上市规则（试行）》、《北京证券交易所上市公司持续监管 指引第 1 号——独立董事》等相关规定，诚实、勤勉、独立地履行职责，积极出 席相关会议，认真审议董事会各项议案，切实维护公司和公众股东的合法权益， 促进公司规范运作，充分发挥了独立董事的作用。现将本人在 2024 年度工作情 况进行汇报如下： 一、会议出席情况 2024 年度，本人积极参加了公司召开的董事会，认真审阅相关资料，参与各 项议题的讨论并提出合理建议，以严谨的态度行使表决权，履行了独立董事的义 务。本年度出席董事会及列席股东大会会议情况如下： | 独立董 | 应出席 | 实际出 | 现场 ...

证券代码：833429 证券简称：康比特 公告编号：2025-034 北京康比特体育科技股份有限公司 董事会关于独立董事独立性自查情况的专项意见 根据中国证券监督管理委员会《上市公司独立董事管理办法》等相关规定， 北京康比特体育科技股份有限公司（以下简称"公司"）董事会就公司在任独 立董事俞放虹、张志军、付立家的独立性情况进行评估并出具了专项意见。 根据独立董事向董事会提供的关于独立性情况的自查报告，结合其他相关 资料，董事会就独立董事的独立性形成如下结论： （一）独立董事及其配偶、父母、子女、具有主要社会关系的人员未在公 司或公司附属企业任职； （二）独立董事及其配偶、父母、子女未直接或间接持有公司已发行股份 百分之一以上，不是公司前十名股东中的自然人股东； （三）独立董事及其配偶、父母、子女不是直接或间接持有公司已发行股 份百分之五以上的股东，未在公司前五名股东任职； （四）独立董事及其配偶、父母、子女未在公司控股股东、实际控制人的 附属企业任职； （五）独立董事不是公司及公司控股股东、实际控制人或者其各自的附属 企业有重大业务往来的人员，未在有重大业务往来的单位及其控股股东、实际 控制人任职； （六）独 ...

证券代码：833429 证券简称：康比特 公告编号：2025-035 北京康比特体育科技股份有限公司舆情管理制度 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 审议及表决情况 公司于 2025 年 4 月 16 日召开第六届董事会第十一次会议决议，审议通过《关 于制定<舆情管理制度>的议案》，该议案无需提交股东大会审议。 二、 制度的主要内容，分章节列示： 北京康比特体育科技股份有限公司 舆情管理制度 第一章 总 则 第一条 为了提高北京康比特体育科技股份有限公司（以下简称"公司"） 应对各类舆情的能力，建立快速反应和应急处置机制，充分发挥网络互动优势， 正确把握和引导网络舆论导向，及时、妥善处理各类舆情对公司股价、公司商业 信誉及正常生产经营活动造成的影响，切实保护投资者合法权益，根据《北京证 券交易所股票上市规则（试行）》等相关法律法规规定和《北京康比特体育科技 股份有限公司公司章程》制订本制度。 第二条 本制度所称舆情包括： （一）报刊、电视、网络等媒体对公司进行的负面报道； （二）社会上 ...

证券代码：833429 证券简称：康比特 公告编号：2025-028 北京康比特体育科技股份有限公司 2024 年度独立董事述职报告（俞放虹） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载，误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为北京康比特体育科技股份有限公司（以下简称"公司"）的独立董事， 2024 年度本人严格按照《中华人民共和国公司法》、《中华人民共和国证券法》、 《北京证券交易所股票上市规则（试行）》、《北京证券交易所上市公司持续监管 指引第 1 号——独立董事》等相关规定，诚实、勤勉、独立地履行职责，积极出 席相关会议，认真审议董事会各项议案，切实维护公司和公众股东的合法权益， 促进公司规范运作，充分发挥了独立董事的作用。现将本人在 2024 年度工作情 况进行汇报如下： 一、会议出席情况 2024 年度，本人积极参加了公司召开的董事会，认真审阅相关资料，参与各 项议题的讨论并提出合理建议，以严谨的态度行使表决权，履行了独立董事的义 务。本年度出席董事会及列席股东大会会议情况如下： | 独立董 | 应出席 | 实际出 | 现场 ...

证券代码：833429 证券简称：康比特 公告编号：2025-030 北京康比特体育科技股份有限公司 2024 年度独立董事述职报告（付立家） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载，误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为北京康比特体育科技股份有限公司（以下简称"公司"）的独立董事， 2024 年度本人严格按照《中华人民共和国公司法》、《中华人民共和国证券法》、 《北京证券交易所股票上市规则（试行）》、《北京证券交易所上市公司持续监管 指引第 1 号——独立董事》等相关规定，诚实、勤勉、独立地履行职责，积极出 席相关会议，认真审议董事会各项议案，切实维护公司和公众股东的合法权益， 促进公司规范运作，充分发挥了独立董事的作用。现将本人在 2024 年度工作情 况进行汇报如下： 一、会议出席情况 2024 年度，本人积极参加了公司召开的董事会，认真审阅相关资料，参与各 项议题的讨论并提出合理建议，以严谨的态度行使表决权，履行了独立董事的义 务。本年度出席董事会及列席股东大会会议情况如下： | 独立董 | 应出席 | 实际出 | 现场 ...

Financial Performance - Operating revenue for the first quarter of 2025 reached CNY 193,752,584.37, representing a year-on-year increase of 26.08%[11] - Net profit attributable to shareholders for the first quarter of 2025 was CNY 12,036,941.28, up 9.66% from the same period last year[11] - Total revenue for Q1 2025 reached ¥193,752,584.37, a significant increase from ¥153,676,683.10 in Q1 2024, representing a growth of approximately 26%[42] - Net profit for Q1 2025 reached CNY 12,036,709.84, an increase of 9.5% compared to CNY 10,995,156.82 in Q1 2024[43] - Basic and diluted earnings per share for Q1 2025 were both CNY 0.10, compared to CNY 0.09 in Q1 2024, indicating a 11.1% increase[44] - Total comprehensive income for Q1 2025 was CNY 12,036,709.84, compared to CNY 10,995,156.82 in Q1 2024, marking a growth of 9.5%[45] Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY 117,262,155.18, a significant decline of 322.16% compared to the previous year[11] - Cash inflow from operating activities in Q1 2025 was CNY 168,207,462.98, slightly up from CNY 167,865,939.47 in Q1 2024[46] - The net cash flow from operating activities was -117,262,155.18 yuan, compared to -27,776,476.13 yuan in the previous year, indicating a significant decline in operational performance[47] - Total cash inflow from operating activities was 198,188,870.74 yuan, while cash outflow was 242,008,072.68 yuan, resulting in a net cash flow of -43,819,201.94 yuan for the current period[48][49] - The ending cash and cash equivalents balance was 307,223,402.68 yuan, down from 343,713,408.93 yuan year-over-year[47] Assets and Liabilities - Total assets as of March 31, 2025, were CNY 1,171,324,695.19, a decrease of 0.69% compared to the end of the previous year[11] - The company's total liabilities as of March 31, 2025, were RMB 314,708,949.37, compared to RMB 320,627,164.03 at the end of 2024[37] - The company's current assets totaled RMB 754,981,365.53, slightly down from RMB 760,988,526.04 at the end of 2024[35] - Total liabilities decreased to ¥219,484,431.03 as of March 31, 2025, down from ¥246,776,215.36 as of December 31, 2024, reflecting a decline of about 11%[41] Shareholder Information - The total number of ordinary shareholders was 5,716 as of the end of the reporting period[18] - The largest shareholder, Beijing Huikang Information Consulting Center, holds 28,461,255 shares, representing 22.86% of total shares[20] - The total shares held by the top ten shareholders amount to 74,890,742, which is 60.15% of the total shares[20] - The company has no pledged or judicially frozen shares among the top shareholders[21] Research and Development - Research and development expenses for Q1 2025 were ¥8,612,602.44, compared to ¥7,460,042.17 in Q1 2024, representing an increase of approximately 15%[42] - Research and development expenses for Q1 2025 amounted to CNY 6,775,364.99, an increase from CNY 5,974,323.69 in Q1 2024, reflecting a growth of 13.4%[44] Share Repurchase and Equity Plans - The company repurchased shares, resulting in treasury stock increasing by 191.90% to CNY 21,773,789.03[13] - The company approved a share repurchase plan with a budget of no less than RMB 10 million and no more than RMB 20 million, with a maximum repurchase price of RMB 13 per share[28] - As of December 31, 2024, the company repurchased 567,746 shares, accounting for 0.46% of the total share capital, with a total expenditure of RMB 5,680,553.06, which is 28.40% of the planned repurchase budget[28] - The maximum repurchase price was adjusted to RMB 25 per share, and the implementation period was extended to March 25, 2025[29] Commitments and Legal Matters - The company has not engaged in any litigation, arbitration, or external guarantees during the reporting period[23] - There are no significant related party transactions or fund misappropriation issues reported[23] - The company has disclosed commitments and has fulfilled them as per the prospectus[24] - The company has ongoing commitments that are being fulfilled as disclosed previously[31]

Product Innovation and Development - In 2024, Kangbiter launched new weight management products and upgraded its whey protein ultra product, winning the "Nutritional Food Technology Innovation Award" at the IWF Shanghai International Fitness Expo[8]. - Kangbiter's whey protein ultra product received widespread recognition, winning the 2024 Global Food Innovation Award bronze medal[9]. - The company is focusing on product innovation, launching the CPT pro specialized nutrition formula whey protein to enhance protein absorption efficiency[49]. - The company has completed the development of white kidney bean extract tablets, targeting consumers who enjoy carbohydrates but are concerned about weight management[95]. - The development of a CLA fish oil fat-reducing beverage has been completed, with successful sensory testing[95]. - The company has achieved batch production of slow-release creatine tablets, expanding its market presence among fitness enthusiasts[95]. - The company has successfully developed a range of ready-to-eat foods, including fried rice and chicken sticks, with plans for mass production and sales[96]. - The company has completed the industrialization of biscuit products, addressing issues related to microbial contamination and improving taste[96]. - The company is in the process of developing a new type of puffed protein bar, focusing on texture and stability improvements[96]. - The company has optimized the production process for energy gels, transitioning from contract manufacturing to in-house production, reducing costs[95]. - The company is developing a high-efficiency peptide drink aimed at post-exercise recovery, with a shelf life of over 12 months[104]. Financial Performance - The company's revenue for 2024 reached ¥1,040,013,192.71, representing a 23.34% increase compared to ¥843,220,191.54 in 2023[31]. - The net profit attributable to shareholders for 2024 was ¥89,313,991.99, a slight increase of 1.38% from ¥88,101,313.18 in 2023[31]. - The gross profit margin for 2024 decreased to 39.41% from 40.09% in 2023[31]. - Total assets at the end of 2024 amounted to ¥1,179,520,735.98, reflecting a 10.34% increase from ¥1,068,961,077.66 at the end of 2023[32]. - The company's total liabilities increased by 18.20% to ¥320,627,164.03 in 2024 from ¥271,250,624.62 in 2023[32]. - The return on equity (ROE) based on net profit attributable to shareholders was 10.76% in 2024, down from 11.50% in 2023[31]. - The company's cash flow from operating activities for 2024 was ¥132,159,732.23, a decrease of 10.83% from ¥148,208,544.00 in 2023[32]. - The accounts receivable turnover ratio improved to 14.84 in 2024 from 11.41 in 2023[33]. - The inventory turnover ratio increased to 3.02 in 2024, compared to 2.82 in 2023[33]. - The company's debt-to-asset ratio (consolidated) was 27.18% in 2024, up from 25.38% in 2023[32]. - The total profit for 2024 is ¥102,713,973.86, showing a minor difference of -0.10% from the earnings forecast[34]. Market Position and Recognition - The company was awarded the "Annual High Growth Award" on the Tmall health platform, leading the health track in the domestic health product industry[8]. - Kangbiter was listed in the "2024 Beijing Manufacturing Enterprises Top 100" and "2024 Beijing Specialized and Innovative Enterprises Top 100," reflecting its recognition in promoting high-quality economic development[10]. - The company established a digital sports health nutrition industry integration community with Beijing Sport University and Guangzhou City Vocational College[7]. - The company achieved a "Five-Star Credit Rating" in the corporate credit rating assessment, showcasing its strong corporate strength and credibility[9]. - The company is positioned in the rapidly growing sports nutrition food industry, with significant market potential due to low product penetration and increasing consumer awareness[53]. - The global sports nutrition market size grew from 16.314 billion USD in 2017 to 18.56 billion USD in 2022, and is projected to reach 25.191 billion USD by 2026[56]. Corporate Governance and Management - The company has established a robust governance structure, ensuring compliance with relevant laws and regulations[178]. - The board of directors consists of 7 members, while the supervisory board has 3 members and there are 6 senior management personnel[158]. - The company has implemented a performance evaluation mechanism for senior management, linking their compensation to performance indicators[198]. - The company maintains independence in operations, personnel, assets, institutions, and finances, ensuring no conflicts with shareholders[194]. - The supervisory board confirmed that the board of directors operated in compliance with resolutions from shareholder meetings, with no major risks identified[193]. Research and Development - The company maintains a robust R&D model, focusing on self-developed products and structured project management[42]. - The procurement system is designed to ensure quality through a multi-level evaluation mechanism for suppliers[43]. - The company applied for 38 patents in 2024, including 3 invention patents, and currently holds 198 authorized patents, comprising 103 invention patents, 60 utility model patents, and 35 design patents[52]. - The total number of R&D personnel decreased slightly to 100, with a proportion of 12.7% of total employees[92]. Strategic Partnerships and Collaborations - The company engaged in deep cooperation discussions with JD Health and Tmall Health to promote the healthy development of the sports nutrition industry[9]. - The company has established partnerships with universities to accelerate technological innovation in the sports nutrition sector[52]. Employee and Shareholder Information - The total number of employees increased from 795 to 901, representing a growth of approximately 13.3%[167]. - The company has a stock incentive plan with 710,000 shares that are currently unexercised[166]. - The company has repurchased 1,366,126 shares, accounting for 1.10% of the total share capital, and spent approximately 19.99 million yuan on this buyback[174]. - The largest shareholder, Beijing Huikang Information Consulting Center, holds 22.86% of the company’s shares, totaling 28,461,255 shares[138]. Risks and Challenges - The company acknowledges significant uncertainties in achieving its 2025 operational goals due to macroeconomic conditions and market demand fluctuations[109]. - The company faces risks related to actual control by major shareholders, which could impact strategic decisions and shareholder interests[110]. - The company recognizes competitive risks from both domestic and international brands in the expanding sports nutrition market[111].

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.1000 | 0.0900 | 11.11 | 0.0900 | | 每股净资产（元） | 6.88 | 6.5 | 5.85 | 6.03 | | 每股公积金(元) | 2.23 | 2.23 | 0 | 2.24 | | 每股未分配利润(元) | 3.32 | 2.81 | 18.15 | 2.38 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.94 | 1.54 | 25.97 | 1.31 | | 净利润(亿元) | 0.12 | 0.11 | 9.09 | 0.11 | | 净资产收益率(%) | 1.39 | 1.37 | 1.46 | 1.44 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 6455.26万股，累计占流通股比： 56.97%，较上期变化： 16 ...

Core Insights - 康比特智慧营养健康餐厅 launched at the 33rd Shanghai International Hotel and Catering Industry Expo, showcasing its "AI Sports Nutritionist" app integrated with DeepSeek model, aligning with the national "Weight Management Year" initiative [1][8] - The restaurant emphasizes personalized nutrition management based on individual health goals, addressing common health issues such as weight loss, muscle gain, and high uric acid levels [3][5] - 康比特's AI platform offers a balanced approach to nutrition and exercise, allowing users to offset excess calorie intake through exercise recommendations, promoting individualized health management [5][7] Industry Trends - The integration of AI technology in dietary services marks a shift from traditional methods to digital solutions, enhancing the quality of nutrition services for both athletes and the general public [8][10] - 康比特's initiative represents a new paradigm in employee welfare, where companies invest in health through digitalized canteen services, enabling employees to manage their health autonomously [10][12] - The use of professional body composition analysis tools at the expo highlights the importance of data-driven personalized nutrition services, which are crucial for effective health management [12][14] Product Features - 康比特智慧营养健康餐厅 offers AI nutrition advice, smart health management, and personalized nutrition reports, attracting significant industry attention [14] - The restaurant's immersive dining experience allows guests to engage with AI-driven meal planning, showcasing the potential for deeper integration of technology in the food service industry [14]